Xponance, Inc. Ab Cellera Biologics Inc. Transaction History

Xponance, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$7.31 - $11.18 $1,198 - $1,833	164 Added 1.39%	12,000 $90,000
Q4 2022 Jan 23, 2023	BUY	$9.48 - $14.52 $2,057 - $3,150	217 Added 1.87%	11,836 $0
Q3 2022 Oct 24, 2022	BUY	$9.2 - $13.68 $4,600 - $6,840	500 Added 4.5%	11,619 $115,000
Q2 2022 Aug 02, 2022	BUY	$5.72 - $10.65 $63,600 - $118,417	11,119 New	11,119 $118,000

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $833M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.